Glenmark Pharmaceuticals Ltd. (Glenmark) a research-led, global pharmaceutical company, has announced the upcoming launch of zanubrutinib in India following approval by the Drugs Controller General of India (DCGI). Click here for more information 👇 https://pharmajobspost.in/glenmark-pharmaceuticals-to-launch-dcgi-approved-brukinsa-in-india-to-advance-treatment-of-hematological-malignancies/